Last reviewed · How we verify

NCT05757986

Predictive Model for PONV for Patient Received Gynecological Laparoscopic Surgery

Status unknown Last updated 15 June 2023
What this trial tests

trial testing The presence of nausea and vomiting within 24 hours after surgery in Postoperative Nausea and Vomiting in 659 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
1 March 2023
1 October 2023

Quick facts

Lead sponsorJiang Liu
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment659
Start date1 September 2022
Primary completion1 March 2023
Estimated completion1 October 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Jiang Liu

Who can join

12 and older, female only, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective study to dynamically predict the risk of PONV in patients undergoing gynecologic laparoscopic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of The presence of nausea and vomiting within 24 hours after surgery

Trials testing the same drug.

Other recruiting trials for Postoperative Nausea and Vomiting

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing